Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain
Mina Tamaru,* Hidetaka Akita,* Taichi Nakatani, Kazuaki Kajimoto, Yusuke Sato, Hiroto Hatakeyama, Hideyoshi Harashima Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan *These authors contributed equally to this work Abstract: An innovative drug delivery technology is urgen...
Guardado en:
Autores principales: | Tamaru M, Akita H, Nakatani T, Kajimoto K, Sato Y, Hatakeyama H, Harashima H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0162472f4ae4ee1a2429eccafdea9ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion
por: Abbasi S, et al.
Publicado: (2016) -
Framework nucleic acids as programmable carrier for transdermal drug delivery
por: Christian Wiraja, et al.
Publicado: (2019) -
Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells
por: Marcin Równicki, et al.
Publicado: (2017) -
Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
por: Xie F, et al.
Publicado: (2012) -
Duplex DNA-Invading γ-Modified Peptide Nucleic Acids Enable Rapid Identification of Bloodstream Infections in Whole Blood
por: Jörk Nölling, et al.
Publicado: (2016)